Last updated: February 19, 2026
Who are the leading suppliers of fluocinonide?
Fluocinonide, a potent topical corticosteroid, is manufactured by several pharmaceutical companies. The market comprises both brand-name and generic manufacturers, with products distributed globally. Key suppliers include:
- Pfizer Inc. (brand: Lidex)
- Mylan N.V. (generic formulations)
- Sun Pharmaceutical Industries Ltd.
- Taro Pharmaceuticals Inc.
- Sandoz (a Novartis division)
- Lupin Limited
These companies supply fluocinonide in various formulations, including creams, ointments, gels, and solutions.
Market Segmentation and Product Formulations
| Company |
Product Name |
Formulations Available |
Market Regions |
| Pfizer |
Lidex |
Cream, ointment |
North America, select international markets |
| Mylan |
Generic fluocinonide |
Cream, gel |
Global |
| Sun Pharma |
Fluocinonide Gel |
Gel |
India, Southeast Asia |
| Taro |
Taro Fluocinonide |
Cream, ointment |
US, Canada |
| Sandoz |
Fluocinonide Sandoz |
Cream, ointment |
Europe, US |
| Lupin |
Lupin Fluocinonide |
Cream, gel |
India, Middle East, Africa |
Distribution Channels
Suppliers distribute fluocinonide through:
- Wholesale distributors: Provide drug wholesalers and clinics.
- Direct sales: To hospitals and healthcare providers.
- Online platforms: For certain generic products, particularly in regions with e-prescription regulations.
Regulatory Approvals and Manufacturing Locations
Major manufacturers operate manufacturing facilities in:
- United States (Pfizer, Taro, Sandoz)
- India (Sun Pharma, Lupin, Lupin)
- Europe (Sandoz)
- Manufacturing compliant with US FDA and EMA standards.
Product approval timelines vary by region, with US FDA approvals dating back to early 2000s for several brands and generics.
Market Trends and Supply Dynamics
- Increasing demand due to topical corticosteroid prescriptions for conditions like psoriasis, dermatitis.
- Growth in generic drug manufacturing, reducing prices and increasing supply.
- Supply chain disruptions occasionally occur due to manufacturing or regulatory delays, affecting availability in some regions.
Key Notes for Stakeholders
- Pfizer's Lidex remains a prominent brand in North America.
- Generics from Mylan, Sun Pharma, Lupin, Taro, and Sandoz dominate global markets.
- Formulation variety supports diverse consumer needs and regional preferences.
References
[1] U.S. Food and Drug Administration. (2022). Drug Applications and Approvals. https://www.fda.gov
[2] IQVIA. (2022). Global Pharmaceutical Market Data. https://www.iqvia.com
[3] GlobalData. (2021). Top Suppliers of Topical Corticosteroids. https://www.globaldata.com
[4] European Medicines Agency. (2022). Marketing Authorisations. https://www.ema.europa.eu
